Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

BACKGROUND: The synergistic combination of interferon (IFN) alpha-2b and IFN gamma results in more potent in vitro biological effects mediated by both IFNs. The aim of this investigation was to evaluate by first time the pharmacokinetics and pharmacodynamics of this combination in patients with myco...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: García-Vega, Yanelda, García-García, Idrian, Collazo-Caballero, Sonia E, Santely-Pravia, Egla E, Cruz-Ramírez, Alieski, Tuero-Iglesias, Ángela D, Alfonso-Alvarado, Cristian, Cabrera-Placeres, Mileidys, Castro-Basart, Nailet, Duncan-Roberts, Yaquelín, Carballo-Treto, Tania I, Soto-Matos, Josanne, Izquierdo-Toledo, Yoandy, Vázquez-Blomquist, Dania, García-Iglesias, Elizeth, Bello-Rivero, Iraldo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2012
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3633053/
https://ncbi.nlm.nih.gov/pubmed/23272809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-13-20
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items